RegisterLogin

VTX-0811

CAT: 804-HY-P991432Size: 1 EachDry Ice: NoHazardous: No
1 EachSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VTX-0811 is a human IgG4 monoclonal antibody (mAb) targeting PSGL1/CD162. VTX-0811 up-regulates TNF-α/NF-κB and chemokine-mediated signaling and down-regulates oxidative phosphorylation, fatty acid metabolism, and Myc signaling pathways. VTX-0811 increases the proportion of CD8+ T cells among infiltrating T cells. VTX-0811 has antitumor activity in a humanized mouse PDX model of melanoma[1].
UNSPSC
12352203
Target
C-Myc; NF-κB; TNF Receptor
Related Pathways
Apoptosis; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[VTX-0811]
References & Citations
[1]Feldman I, et al. VTX-0811, a first-in-class PSGL-1 blocking monoclonal antibody, repolarizes tumor associated macrophages and induces inflammation in the tumor microenvironment, leading to suppression of tumor growth in pre-clinical studies[J]. Cancer Research, 2022, 82 (12_Supplement) : 5602-5602.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991181VTX-1218
HY-112782-01VTX-27
HY-U00141-01ABTL-0812
HY-50669-01MK-0812
HY-145409-01SR-0813
HY-50669A-01MK-0812 (Succinate)

Alternative Products

CatalogName
T9901A-1683-01VTX-0811
DHG76503Research Grade Anti-Human CD162/SELPLG/PSGL-1 (VTX 0811)
A136803Anti-CD162/SELPLG/PSGL-1 (VTX 0811) Biosimilar (Monoclonal, IgG)
HC298036-01Research Grade Anti-Human CD162/SELPLG/PSGL-1 (VTX 0811)
MBS1581553-01Research Grade Anti-Human CD162/SELPLG/PSGL-1 (VTX 0811)
35-441Cytomegalovirus Antibody [0811]
MBS386381-01VTX-2337
215893-01VTX-27
T13314-01VTX-27
BA4960-10VTX-27

Popular Products